Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
University of Southampton
NRG Oncology
UroGen Pharma Ltd.
UroGen Pharma Ltd.
City of Hope Medical Center
Maimónides Biomedical Research Institute of Córdoba
Federation Francophone de Cancerologie Digestive
National Health Research Institutes, Taiwan
Abnoba Gmbh
Tongji Hospital
Alliance for Clinical Trials in Oncology
Merck Sharp & Dohme LLC
UroGen Pharma Ltd.
UroGen Pharma Ltd.
Nottingham University Hospitals NHS Trust
UroGen Pharma Ltd.
National Cancer Institute (NCI)
University of Sydney
Corewell Health West
Blokhin's Russian Cancer Research Center
UroGen Pharma Ltd.
American College of Radiology Imaging Network
UroGen Pharma Ltd.
Medical Enterprises Ltd.
Asan Medical Center
Samyang Biopharmaceuticals Corporation
University of Erlangen-Nürnberg Medical School
Radiation Therapy Oncology Group
Sun Yat-sen University
Memorial Sloan Kettering Cancer Center
Asan Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Yale University
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Stanford University
University of Rome Tor Vergata
University of Rome Tor Vergata